Benzinga's Top Upgrades
Analysts at Credit Suisse upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from “neutral” to “outperform.” The target price for Cubist Pharmaceuticals has been raised from $56 to $69. Cubist's shares closed at $57.00 yesterday.
Analysts at Benchmark upgraded Open Text (NASDAQ: OTEX) from “hold” to “buy.” The target price for Open Text is set to $85. Open Text's shares closed at $67.46 yesterday.
Analysts at Piper Jaffray upgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from “neutral” to “overweight.” The target price for Questcor Pharmaceuticals has been raised from $41 to $74. Questcor's shares closed at $51.91 yesterday.
Analysts at JP Morgan upgraded Compass Minerals International (NYSE: CMP) from “underweight” to “neutral” The target price for Compass Minerals International has been raised from $65 to $66. Compass Minerals International's shares closed at $73.06 yesterday.
Latest Ratings for CBST
Date | Firm | Action | From | To |
---|---|---|---|---|
Dec 2014 | UBS | Downgrades | Buy | Neutral |
Dec 2014 | Oppenheimer | Downgrades | Outperform | Market Perform |
Dec 2014 | Mizuho | Downgrades | Buy | Neutral |
View More Analyst Ratings for CBST
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: top upgradesUpgrades Analyst Ratings